KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Change in Cash (2016 - 2026)

Medtronic's Change in Cash history spans 12 years, with the latest figure at -$136.0 million for Q1 2026.

  • For Q1 2026, Change in Cash rose 11.69% year-over-year to -$136.0 million; the TTM value through Jan 2026 reached -$94.0 million, up 75.46%, while the annual FY2025 figure was $934.0 million, 460.62% up from the prior year.
  • Change in Cash for Q1 2026 was -$136.0 million at Medtronic, down from $9.0 million in the prior quarter.
  • Across five years, Change in Cash topped out at $2.7 billion in Q4 2022 and bottomed at -$3.0 billion in Q2 2023.
  • The 5-year median for Change in Cash is -$28.0 million (2023), against an average of -$103.2 million.
  • The largest annual shift saw Change in Cash surged 2684.62% in 2022 before it tumbled 3600.0% in 2025.
  • A 5-year view of Change in Cash shows it stood at $2.7 billion in 2022, then crashed by 101.04% to -$28.0 million in 2023, then skyrocketed by 396.43% to $83.0 million in 2024, then tumbled by 89.16% to $9.0 million in 2025, then crashed by 1611.11% to -$136.0 million in 2026.
  • Per Business Quant, the three most recent readings for MDT's Change in Cash are -$136.0 million (Q1 2026), $9.0 million (Q4 2025), and -$945.0 million (Q3 2025).